ionispharma.com (IONS) - Cash on Hand per Share

Corporate emblem and logo of Isis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS) is recognized as an authoritative innovator in the field of RNA therapeutics. The business model relies on the global sale of patented products following a phase of costly development. The company's cash per share demonstrates financial stability, where the value of 11.27 corresponds to the current metric. A strategy of absolute leadership implies a transition toward independent commercialization of drugs to maximize profit retention.

ionispharma.com (IONS): Cash per Single Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for Ionis Pharmaceuticals, Inc. (IONS)

- stock value and consensus price forecast:
- cash position and cash flow details:
Summary company analysis:IONS, Isis Pharmaceuticals
Manufactured product of Ionis

This indicator determines the portion of liquid capital attributable to a single common share by dividing total cash holdings by the number of issued securities. By analyzing liquid assets per share, an investor assesses the financial stability of Ionis Pharmaceuticals (IONS), whose patent-protected antisense RNA therapy platform and licensing agreements with pharma behemoths ensure a steady influx of resources for further development.

Analysis of competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|RGEN - Cash on Hand per Share|Cash Funds per Share Avidity RNA|Cash per Share CRISPR Therapeutics Corp CRSP|GeneDx Corp - Cash per Share|Ultragenyx Pharma (RARE) - Cash per Single Share|beamtx.com (BEAM) - Cash Funds per Share|SRPT: Cash Calculated per Single Share|Cash per Single Share TWST|TXG - Cash Funds Volume per Share|Cash per Share NTLA|Cash Funds Calculated per Share Stoke Therapeutics|Cash Funds per Share BioLife Solutions BLFS|Wave Life Sciences (WVE) - Cash on Hand per Share|Maze Therapeutics, Inc. - Cash per Share|Cash Funds Calculated per Share Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Cash Funds per Share|TSHA: Cash Calculated per Single Share|Cash Funds per Share uniQure Pharma|MGTX - Cash Funds Volume per Share|Cash per Share RGNX|Cash Funds per Share SLDB (Solid Biosciences)|Ocugen Corp - Cash per Single Share|PACB: Cash Funds per Single Share|benitec.com - Cash per Share|DSGN - Cash per Share|RCKT: Cash per Share|FDMT (4D Molecular Therapeutics Inc) - Cash Funds per Share|Cash per Single Share LXEO|Cash Funds per Share KRRO|Cash per Share EDIT|SLN - Cash on Hand per Share|Cash per Share PRQR (ProQR)|CDXS - Cash per Single Share|Sangamo Therapeutics Inc. - Cash per Share|NAUT - Cash per Share|MGX: Cash per Share|Cash per Single Share Precision BioSciences, Inc.|GBIO (Generation Bio) - Cash per Share|Boundless Bio Inc. (BOLD) - Cash Funds Calculated per Share|Cash per Single Share XCUR (exicuretx.com)|Imunon Inc - Cash Funds per Single Share|Cash per Share PHIO (Phio Pharmaceuticals Corp)|Amount of Cash per Share MBIO|RNAZ - Cash Funds per Share|Amount of Cash per Share BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology